| (JPY) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 11.26B | — |
| Operating expense | — | — |
| Net income | 1.79B | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 4565.T returned +16.4% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +32.8% |
| 1 year | +16.4% |
| 5 years | -37.5% |
| 10 years | -73.5% |
| All-time high | ¥5,618 (Apr 2016) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what ¥1,000 in 4565.T would be worth today ›No. Nxera Pharma Co., Ltd. has not paid a dividend in the past 12 months.
Nxera Pharma Co., Ltd. is part of the Healthcare sector.
Nxera Pharma Co., Ltd. has a market cap of 101.64B JPY, based on the latest quote.
Nxera Pharma Co., Ltd. is expected to report earnings around Oct 30, 2026. That date is an estimate and has not been confirmed by the company.
